Pep2Tango Therapeutics
About:
Pep2Tango Therapeutics is a biotechnology company that offers superior unimolecular multi-receptor drugs for obesity and related disorders.
Top Investors: Versant Ventures
Description:
Total Funding Amount:
$16.7M
Headquarters Location:
Potomac, Maryland, United States
Founded Date:
2021-01-01
Founders:
Cristina Rondinone
Number of Employees:
1-10
Last Funding Date:
2024-11-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai